Clinical Trials Browser

Phase 1/2 × Solid Cancers × 90 days × Clear all

NCT07510841 2026-04-06

JY016 Injection in Patients With Advanced Solid Tumors Expressing EGFR

Phase 1/2 Not yet recruiting

Solid Cancers